« Dashboard

CAPLIPOINT ☆ BSE also on NSE

CAPLIN POINT LABORATORIES LTD. · code 524742 · INE475E01026 · Pharma & Healthcare · series A · Daily price history

2,085.40 -0.20 (-0.01%) close on 19 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityStrongROE 21.8%, ROCE 26.3%, almost no debt
GrowthNot knownNeeds at least 3 years of results. More years load on later visits.
ValuationCheapP/E 34.6 vs sector median 44.6, 6.8x book
MomentumMixedBelow its 200-day average, beat NIFTY 50 by 10.1 points
RiskMediumSwings 36% a year, fell up to 27% from a peak, beta 0.76

Smart Investor Tips: CAPLIPOINT

Constructive Setup (Trend + Fundamentals Aligned)

Actionable Insights & Positives

  • RSI is oversold at 30 (< 30). Watch for a bullish reversal candle (hammer or engulfing) with volume confirmation.
  • Strong earnings compounding: net profit grew at 21.5% CAGR over 1 years.
  • High capital efficiency: ROE of 21.8% indicates strong returns on shareholder equity.
  • Attractive relative valuation: P/E of 34.6x is at a discount to the sector median of 44.6x.

BSE Authentic Bhavcopy & Cross-Exchange Check No API Key

Runs authentic BSE price & volume verification (latest BSE Bhavcopy snapshot, split-adjusted 52W High/Low, 20/50/200 DMA alignment, and 20-day volume trend, plus cross-listed NSE MCP check when shared by ISIN).

Algorithmic Buy / Sell Prediction & Optimal Entry PriceHOLD / ACCUMULATE ON SUPPORT (Score 46/100)

Consolidating. If buying, accumulate only on dips into support at Rs 1,918.57 – Rs 2,085.40 (Ideal ~Rs 2,001.99). Review if price closes below Rs 1,766.65; upside resistance near Rs 2,595.50.

Optimal Buy ZoneTranche 1 (50%)Tranche 2 (50%)Stop-Loss / ReviewTarget 1 (Swing)Target 2 (Breakout)Risk : Reward
Rs 1,918.57 – Rs 2,085.40
Ideal ~Rs 2,001.99
Rs 2,085.40 Rs 1,918.57 Rs 1,766.65
ATR 4.9%
Rs 2,595.50 Rs 2,990.60 1 : 2.5
RSI 31 · Vol 0.39x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 6M change +4.9% · high 2,990.60 · low 1,949.90 · max drawdown -27.2%

Live Candlestick & TradingView Chart (CAPLIPOINT)

MARKET CLOSED — EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures results FY24, price 19 Nov

P/E34.6sector median 44.6
P/B6.84xprice / book value
EPSRs 60.19grew 21.3% a year
Dividend yield-from saved dividend events
Debt to equity0.00xmore cash than debt
Sales growth15.5%a year over 1 years
Profit growth21.5%a year over 1 years
Operating margin32.6%net margin 27.0%

From the official NSE results filings, consolidated. P/E uses the last full year's EPS, PEG 1.61, EV/EBITDA 27.7. See all years.

Company Debt, Borrowings & Cash Flow Health (Official FY24 Consolidated Filing)

Auto-extracted from official NSE/BSE XBRL Balance Sheet & Cash Flow statements (Rs Crore).

Strong Balance Sheet & Cash Flow · Score 93/100
Total Debt / Loans Rs 1.20 Cr Reduced Rs 2.21 Cr YoY
Cash & Bank Balances Rs 553 Cr Liquid cash & equivalents
Net Debt (Loans − Cash) Net Cash Rs 552 Cr Debt-free on net basis
Debt to Equity & Interest Cover 0.00x D/E Interest cover: 724.6x EBIT
Operating Cash Flow (OCF) Rs 311 Cr OCF/PAT conversion: 68%
Free Cash Flow (FCF) Rs 165 Cr After Capex of Rs 146 Cr
  • Net Cash / Debt-Free balance sheet (Cash Rs 553 Cr exceeds Total Loans Rs 1.20 Cr).
  • De-leveraging: reduced total debt by Rs 2.21 Cr YoY.
  • Strong loan interest coverage (724.6x EBIT/Interest).
  • Positive Free Cash Flow (Rs 165 Cr after Capex) available for debt reduction & dividends.

About CAPLIN POINT LABORATORIES

No company description saved yet. Use Profile below to read about this company.

Listed on BSE NSE

Market capNot available
First listed23 Jun 2014BSE not available · NSE 23 Jun 2014
Face valueRs 2
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed

NSE: listing date, face value

Not checked yet.

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 70.57% 0.00 pp, public 29.43%, as on 30 Sep 2026. Holder names and history

Day range2,013.55 to 2,105.00Open 2,050.10
52-week high2,990.60 -30.3% from high (24 Sep 2026)
52-week low1,502.45 +38.8% from low (30 Mar 2026)
Volume22,623 2.1x the 20-day average
RSI (14)30 oversold
Volatility (30d)37.7%annualised
1,502.45
2,990.60

Returns

1W-12.7%
1M-7.8%
3M-17.6%
6M+3.1%
1Y+8.1%
YTD+13.3%
3Y a year+17.5%
5Y a year+19.9%

Against the NIFTY 50

PeriodCAPLIPOINTNIFTY 50Difference
1M-7.8%+11.5% -19.3 pts
3M-17.6%+5.3% -22.9 pts
6M+3.1%+7.9% -4.7 pts
1Y+8.1%-2.1% +10.1 pts

Risk over the past year

Volatility36%medium
Deepest fall-27.2%from a peak
Beta0.76moves less than the index
Best day+9.8%14 May 2026
Worst day-7.4%18 Nov 2026
Up days48%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 246 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

🛡 Forensic Financial Health: Piotroski F-Score & 3-Step DuPont ROE Decomposition

Institutional balance-sheet quality, earnings-to-cash conversion, and ROE driver breakdown from official XBRL filings.

Piotroski F-Score: 6 / 9 · Solid Financial Health
3-Step DuPont ROE Identity: High Pricing Power & Margin Leader
Net Margin: 27.0% × Asset Turnover: 0.63x × Equity Multiplier: 1.16x = ROE 21.8%
✓ Positive Net Profit (PAT > 0) Rs 457 Cr
✓ Positive Operating Cash Flow (OCF > 0) Rs 311 Cr
⚠ High Cash Conversion (OCF >= 85% of PAT) 68% conversion
⚠ Improving Return on Assets (ROA YoY) 16.9% vs 17.2%
✓ Conservative / Decreasing Debt-to-Equity 0.00x (prev 0.00x)
✓ Healthy Balance Sheet Asset Coverage 8.16x
✓ Institutional Return on Equity (ROE >= 14%) 21.8%
✓ Stable / Expanding Profit Margin YoY 27.0% vs 25.7%
⚠ Asset Turnover Efficiency (Sales / Assets) 0.63x

Quarterly Results (Last 8 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales / Revenue 185502510534543600610630
Sales QoQ % -10.9%+171.0%+1.6%+4.7%+1.7%+10.5%+1.7%+3.3%
Operating Profit 77.4168177189189204213223
Operating Margin (OPM %) 41.8%33.5%34.7%35.4%34.8%34.0%34.9%35.4%
Net Profit (PAT) 74.7145151160166173179182
Profit QoQ % -29.3%+94.1%+4.1%+6.0%+3.8%+4.2%+3.5%+1.7%
Profit YoY % +34.7%+107.5%+108.2%+51.3%+122.2%+19.3%+18.5%+13.8%
Net Margin % 40.3%28.9%29.6%30.0%30.6%28.8%29.3%28.9%

Sales and profit Rs crore, consolidated

Sales growth+15.5%a year, 1Y
Profit growth+21.5%a year, 1Y
EPS growth+21.3%a year, 1Y
Avg ROE20.9%2 years

Profit and loss

Rs croreFY23FY24
Sales1,4671,694
Sales growth-+15.5%
Operating profit441552
Operating margin30.1%32.6%
Other income56.066.9
Interest0.780.78
Depreciation45.053.4
Profit before tax451564
Tax rate16.5%18.3%
Net profit376457
Profit growth-+21.5%
Net margin25.7%27.0%
EPS (Rs)49.6260.19

Balance sheet

Rs croreFY23FY24
Equity (net worth)1,8802,316
Borrowings3.411.20
Cash493553
Total assets2,1912,697
Debt to equity0.00x0.00x

Debt, Loans, Cash Flow & Working Capital

Rs croreFY23FY24
Operating Cash Flow (OCF)272311
Capital Expenditure (Capex)194146
Free Cash Flow (FCF = OCF - Capex)77.9165
OCF / Net Profit Conversion0.72x0.68x
Total Borrowings / Loans3.411.20
Cash & Bank Balances493553
Trade Receivables (Cr)394543
Receivable Days98.06x116.93x
Inventories (Cr)288363
Inventory Days71.72x78.22x

Returns on capital

Rs croreFY23FY24
ROE20.0%21.8%
ROCE23.5%26.3%
Interest cover579.65x724.63x

Read from the official annual results filed with NSE (XBRL), consolidated figures. ROE uses average equity of the year and the year before when both are saved, ROCE uses profit before interest and tax over total assets less current liabilities. EPS is per today's share. More years are loading and will appear on a later visit. Check the annual report before investing.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
ALIVUSALIVUS LIFE SCIENCES LIMITED 1,449.85 +0.3% - 17,768 37.7 7.6 20.2% 20.6%
CAPLIPOINTCAPLIN POINT LABORATORIES LTD. 2,085.40 -0.0% - 15,839 34.6 6.8 19.7% 27.0%
ASTRAZENASTRAZENECA PHARMA INDIA LTD. 6,120.45 +1.9% - 15,301 94.7 21.5 22.7% 12.5%
AARTIPHARMAarti Pharmalabs Limited 1,024.80 +1.3% - 9,287 42.8 5.3 12.3% 11.7%
BLUEJETBlue Jet Healthcare Limited 516.80 -0.2% - 8,964 54.7 10.6 19.4% 23.0%
CIPLACIPLA LTD. 1,416.00 -0.3% - - 29.5 - - 13.7%
ALKEMAlkem Laboratories Limited 5,145.00 -1.1% - - 26.7 - 17.0% 16.0%
DIVISLABDIVIS LABORATORIES LTD. 11,178.00 +1.0% - - 115.6 - 15.3% 24.3%
WOCKPHARMAWOCKHARDT LTD. 2,186.60 +7.9% - - - - - -
RUBICONRUBICON RESEARCH LIMITED 1,726.00 +3.9% - - - - - -
APOLLOHOSPAPOLLO HOSPITALS ENTERPRISE LT 8,744.80 -0.8% - - 64.8 - 21.1% 7.9%
RAINBOWRainbow Children's Medicare Li 1,241.45 -1.3% - - - - - -
Sector median- 44.67.617.0%

The 12 largest of 80 stocks in this sector on BSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 19 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is below its 50-day average 20-day average is below the 50-day (short-term downtrend) Price is below its 200-day average (long-term downtrend) RSI 30: oversold zone, a bounce is more likely Volume is 2.1x the 20-day average

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the lower half of its 1-year range and is lower than it was on 46% of days in the past year.

Support (prices below today's)

20-day low2,013.55-3.4%
60-day low2,013.55-3.4%
52-week low1,502.45-28.0%

Resistance (prices above today's)

200-day average2,198.27+5.4%
50-day average2,502.36+20.0%
20-day high2,595.50+24.5%
60-day high2,990.60+43.4%

Zones buyers often watch

Lower quarter of the 1-year range 1,502.45 to 1,874.49 Historically the cheapest part of the past year.
Pullback of 10% to 20% from the high 2,392.48 to 2,691.54 A common area for dips inside an uptrend.
Around the 200-day average 2,132.32 to 2,264.22 Long-term trend line, often watched as support.

Deepest fall from a peak in the past year: -27.2%. Currently -27.2% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average2,332.14 Price is 10.6% below
50-day average2,502.36 Price is 16.7% below
200-day average2,198.27 Price is 5.1% below
RSI (14)30Oversold zone
MACD (12, 26, 9)-69.42Below its signal line (momentum fading)
Volatility (30d)37.7%Medium yearly swings

Support and resistance

R22,159.43
R12,122.42
Pivot2,067.98
S12,030.97
S21,976.53

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-19 2,050.10 2,105.00 2,013.55 2,085.40 -0.01% 22,623
2026-11-18 2,233.90 2,239.00 2,071.75 2,085.60 -7.35% 62,329
2026-11-17 2,325.10 2,389.35 2,211.10 2,251.10 -3.98% 13,919
2026-11-16 2,377.60 2,387.95 2,325.65 2,344.45 -1.76% 5,662
2026-11-13 2,387.90 2,419.00 2,346.00 2,386.50 -0.08% 11,395
2026-11-12 2,550.15 2,564.70 2,370.10 2,388.40 -5.26% 28,716
2026-11-11 2,522.70 2,535.00 2,491.60 2,520.95 +0.80% 4,703
2026-11-09 2,458.95 2,595.50 2,454.75 2,501.05 +2.10% 14,212
2026-11-06 2,410.00 2,410.00 2,362.00 2,381.35 -1.70% 4,765
2026-11-05 2,424.65 2,447.80 2,413.60 2,422.55 +0.27% 5,740
2026-11-04 2,358.00 2,422.45 2,352.00 2,416.10 +2.29% 4,444
2026-11-03 2,385.00 2,385.00 2,329.00 2,362.00 +1.03% 5,056
2026-11-02 2,366.80 2,366.80 2,320.50 2,337.85 +0.56% 1,302
2026-10-30 2,391.25 2,422.70 2,308.75 2,324.85 -2.05% 5,703
2026-10-29 2,358.50 2,409.90 2,342.60 2,373.60 +0.47% 7,109
2026-10-28 2,363.65 2,375.65 2,331.35 2,362.55 +0.35% 4,341
2026-10-27 2,299.45 2,370.00 2,271.55 2,354.35 +3.65% 4,517
2026-10-26 2,212.45 2,306.20 2,212.45 2,271.50 +2.22% 9,026
2026-10-23 2,240.75 2,262.40 2,191.55 2,222.15 -1.26% 10,845
2026-10-22 2,195.60 2,256.80 2,177.00 2,250.40 +1.31% 4,226
2026-10-21 2,255.45 2,271.80 2,209.25 2,221.20 -1.81% 12,405
2026-10-19 2,303.60 2,321.00 2,256.30 2,262.05 -1.66% 4,192
2026-10-16 2,312.75 2,331.35 2,289.55 2,300.20 -0.12% 10,105
2026-10-15 2,338.30 2,361.40 2,294.30 2,303.05 -1.45% 3,380
2026-10-14 2,368.05 2,396.00 2,320.65 2,336.95 -0.99% 6,490
2026-10-13 2,414.15 2,414.55 2,328.00 2,360.25 -2.47% 17,326
2026-10-12 2,439.95 2,455.70 2,385.80 2,420.05 -1.61% 9,078
2026-10-09 2,538.40 2,577.65 2,430.00 2,459.55 -3.57% 22,109
2026-10-08 2,650.95 2,650.95 2,527.75 2,550.65 -3.78% 8,454
2026-10-07 2,679.10 2,687.95 2,610.00 2,650.95 -1.05% 6,090
2026-10-06 2,627.75 2,689.00 2,585.00 2,679.15 +2.90% 6,298
2026-10-05 2,593.25 2,624.00 2,541.05 2,603.65 -1.09% 14,646
2026-10-01 2,732.30 2,732.30 2,558.50 2,632.35 -2.82% 6,794
2026-09-30 2,779.30 2,794.00 2,665.00 2,708.80 -1.26% 7,095
2026-09-29 2,863.40 2,867.00 2,733.50 2,743.40 -3.83% 5,940
2026-09-28 2,835.15 2,871.80 2,799.45 2,852.70 +0.60% 13,995
2026-09-25 2,883.05 2,908.45 2,783.40 2,835.80 -1.05% 7,981
2026-09-24 2,777.90 2,990.60 2,770.00 2,865.80 +2.67% 58,430
2026-09-23 2,773.80 2,833.95 2,773.80 2,791.30 +0.43% 7,046
2026-09-22 2,743.70 2,838.90 2,710.00 2,779.30 +0.81% 11,181
2026-09-21 2,760.00 2,815.95 2,710.00 2,756.90 +0.33% 3,266
2026-09-18 2,593.90 2,773.70 2,593.90 2,747.85 +5.87% 13,055
2026-09-17 2,583.05 2,631.00 2,578.20 2,595.45 +0.45% 5,419
2026-09-16 2,577.70 2,605.75 2,490.35 2,583.70 +0.50% 26,442
2026-09-15 2,784.90 2,784.90 2,560.00 2,570.80 -6.68% 9,379
2026-09-11 2,789.00 2,789.00 2,717.20 2,754.75 -1.37% 6,547
2026-09-10 2,704.40 2,840.95 2,704.40 2,793.00 +2.43% 20,070
2026-09-09 2,773.10 2,799.00 2,710.00 2,726.65 -1.76% 13,988
2026-09-08 2,832.95 2,849.90 2,748.50 2,775.45 -1.35% 9,319
2026-09-07 2,802.90 2,833.60 2,783.50 2,813.55 +0.12% 3,834
2026-09-04 2,867.10 2,867.10 2,759.05 2,810.25 -1.14% 14,716
2026-09-03 2,700.25 2,874.00 2,671.75 2,842.80 +4.72% 34,461
2026-09-02 2,734.85 2,734.85 2,651.00 2,714.70 +0.14% 17,888
2026-09-01 2,532.25 2,752.55 2,521.40 2,710.95 +7.69% 77,720
2026-08-31 2,511.85 2,584.50 2,491.95 2,517.25 +0.05% 5,166
2026-08-28 2,549.00 2,594.80 2,509.35 2,516.10 -1.02% 6,889
2026-08-27 2,536.40 2,549.00 2,501.00 2,542.15 +0.92% 7,325
2026-08-26 2,474.00 2,537.30 2,455.00 2,519.00 +1.90% 52,788
2026-08-25 2,497.20 2,517.00 2,460.15 2,471.95 -0.98% 75,094
2026-08-24 2,547.00 2,551.10 2,477.00 2,496.45 -2.41% 8,010
2026-08-21 2,525.45 2,567.00 2,525.45 2,558.10 +1.09% 5,284
2026-08-20 2,589.55 2,597.60 2,521.15 2,530.40 -1.58% 5,867
2026-08-19 2,532.00 2,588.00 2,515.45 2,571.00 +1.61% 7,230
2026-08-18 2,530.00 2,558.95 2,507.00 2,530.15 +0.38% 2,351
2026-08-17 2,454.30 2,529.25 2,441.10 2,520.55 +1.61% 9,314
2026-08-14 2,512.80 2,518.50 2,460.05 2,480.60 -0.71% 2,916
2026-08-13 2,449.75 2,519.00 2,381.00 2,498.25 +0.93% 15,912
2026-08-12 2,638.80 2,661.85 2,455.00 2,475.20 -5.68% 19,726
2026-08-11 2,608.45 2,654.75 2,605.00 2,624.15 +0.08% 4,811
2026-08-10 2,501.95 2,662.80 2,501.95 2,622.00 +1.82% 8,448
2026-08-07 2,607.65 2,607.65 2,560.00 2,575.05 -0.37% 1,898
2026-08-06 2,579.10 2,598.45 2,542.90 2,584.55 +1.62% 5,764
2026-08-05 2,558.00 2,580.15 2,533.40 2,543.25 -1.06% 1,565
2026-08-04 2,553.35 2,611.00 2,546.00 2,570.40 +0.26% 1,466
2026-08-03 2,510.00 2,586.80 2,500.00 2,563.80 +1.95% 3,488
2026-07-31 2,534.10 2,550.85 2,497.00 2,514.70 -0.77% 2,170
2026-07-30 2,590.05 2,637.00 2,515.70 2,534.10 -2.93% 4,279
2026-07-29 2,590.00 2,638.10 2,589.00 2,610.60 +0.82% 3,842
2026-07-28 2,631.10 2,675.00 2,580.00 2,589.25 -1.29% 9,131
2026-07-27 2,465.00 2,653.15 2,465.00 2,623.15 +6.43% 13,563
2026-07-24 2,458.00 2,514.40 2,455.20 2,464.65 -0.90% 8,465
2026-07-23 2,461.05 2,545.50 2,455.00 2,487.15 +0.25% 9,678
2026-07-22 2,602.05 2,605.30 2,460.10 2,480.95 -4.84% 9,799
2026-07-21 2,664.85 2,664.85 2,603.15 2,607.05 -1.54% 3,049
2026-07-20 2,620.00 2,680.00 2,620.00 2,647.75 +1.29% 2,358
2026-07-17 2,653.85 2,659.80 2,575.05 2,614.00 -2.16% 9,260
2026-07-16 2,642.65 2,683.05 2,598.30 2,671.70 +0.78% 19,698
2026-07-15 2,660.65 2,700.00 2,632.80 2,651.05 -0.26% 5,869
2026-07-14 2,649.60 2,679.00 2,596.05 2,658.05 +1.57% 15,555
2026-07-13 2,583.70 2,637.95 2,563.15 2,616.90 +1.22% 14,576
2026-07-10 2,627.05 2,689.00 2,565.10 2,585.40 -1.34% 5,832
2026-07-09 2,558.00 2,636.00 2,550.10 2,620.40 +3.69% 5,919
2026-07-08 2,565.65 2,620.00 2,503.40 2,527.20 -1.52% 6,266
2026-07-07 2,638.40 2,649.00 2,551.00 2,566.10 -2.25% 24,430
2026-07-06 2,545.25 2,639.60 2,545.25 2,625.15 +3.54% 12,008
2026-07-03 2,535.15 2,630.90 2,505.00 2,535.35 -0.47% 18,157
2026-07-02 2,566.35 2,579.00 2,511.15 2,547.20 -0.58% 8,483
2026-07-01 2,655.45 2,680.00 2,550.00 2,562.15 -2.36% 8,497
2026-06-30 2,571.35 2,674.95 2,571.35 2,624.15 +2.57% 40,264
2026-06-29 2,507.25 2,587.00 2,486.80 2,558.40 +2.04% 20,602
2026-06-25 2,527.20 2,544.00 2,474.05 2,507.25 -0.44% 2,924
2026-06-24 2,485.00 2,587.00 2,477.15 2,518.25 +1.05% 19,291
2026-06-23 2,540.00 2,550.00 2,460.00 2,492.20 -1.68% 5,859
2026-06-22 2,519.20 2,550.00 2,487.80 2,534.90 +1.15% 17,779
2026-06-19 2,358.50 2,560.00 2,340.35 2,506.15 +6.22% 34,456
2026-06-18 2,359.75 2,383.00 2,340.35 2,359.45 +1.12% 2,914
2026-06-17 2,409.95 2,409.95 2,325.00 2,333.25 -1.88% 13,064
2026-06-16 2,383.75 2,415.00 2,340.00 2,377.85 +0.60% 5,390
2026-06-15 2,423.45 2,445.00 2,349.00 2,363.65 -1.98% 18,984
2026-06-12 2,342.95 2,424.00 2,342.95 2,411.30 +3.45% 11,551
2026-06-11 2,312.35 2,375.10 2,286.60 2,330.80 +0.99% 14,610
2026-06-10 2,260.30 2,407.20 2,247.00 2,308.00 +2.23% 77,262
2026-06-09 2,124.95 2,281.00 2,124.95 2,257.60 +7.00% 29,424
2026-06-08 2,018.05 2,149.35 2,006.45 2,110.00 +3.87% 19,801
2026-06-05 2,039.95 2,047.85 2,015.95 2,031.45 +0.83% 3,609
2026-06-04 1,960.60 2,040.60 1,960.60 2,014.65 +2.03% 9,077
2026-06-03 1,978.30 1,993.10 1,954.20 1,974.55 -0.61% 1,511
2026-06-02 2,008.00 2,008.00 1,965.00 1,986.65 -0.49% 3,009
2026-06-01 2,064.90 2,072.45 1,992.00 1,996.40 -1.66% 12,975
2026-05-29 2,017.35 2,085.75 2,011.40 2,030.10 +0.28% 11,040
2026-05-27 2,047.00 2,061.00 2,015.00 2,024.50 -0.54% 2,631
2026-05-26 2,095.30 2,097.00 2,027.65 2,035.45 -1.92% 4,428
2026-05-25 2,061.05 2,090.00 2,031.60 2,075.20 +2.29% 14,959
2026-05-22 2,023.40 2,057.00 2,014.00 2,028.75 +0.31% 5,739
2026-05-21 2,026.55 2,051.00 1,999.60 2,022.45 +0.31% 6,498
2026-05-20 2,047.00 2,067.65 2,010.00 2,016.30 -1.06% 12,380
2026-05-19 1,980.80 2,059.90 1,980.80 2,037.90 +2.53% 26,489
2026-05-18 1,990.00 2,046.30 1,949.90 1,987.55 -0.57% 21,139

Latest news More

Shareholding pattern

Up to dateNSE listingChecks passed

Quarter ended 30 Sep 2026, filed 21 Oct 2026. Latest filing is for the expected quarter (Sep 2026). Company: CAPLIN POINT LAB LTD., ISIN INE475E01026.

Promoters and group
70.57%
0.00 pp vs Jun 2026
Public (all, Category B)
29.43%
0.00 pp vs Jun 2026

Foreign, domestic institution and mutual fund lines need the filing file for the period. An admin can load them under Admin > Shareholding tracker.

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Jun 26)Latest (Sep 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group70.57%70.57%0.00 pp-0.00 ppNo material change.
Public (all, Category B)29.43%29.43%0.00 pp-0.00 ppNo material change.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

No rule was triggered by the data in the database. That is not a clean bill of health: the rules look only at reported holdings.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

The exchange listing has no filing file for this stock, so holder names are not available.

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Sep 202670.57%0.00 pp29.43%0.00 pp21 Oct 2026NSE
Jun 202670.57%0.00 pp29.43%0.00 pp21 Jul 2026NSE
Mar 202670.57%0.00 pp29.43%0.00 pp21 Apr 2026NSE
Dec 202570.57%0.00 pp29.43%0.00 pp19 Jan 2026NSE
Sep 202570.57%+0.01 pp29.43%-0.01 pp16 Oct 2025NSE
Jun 202570.56%0.00 pp29.44%0.00 pp17 Jul 2025NSE
Mar 202570.56%0.00 pp29.44%0.00 pp18 Apr 2025NSE
Dec 202470.56%0.00 pp29.44%0.00 pp20 Jan 2025NSE
Sep 202470.56%0.00 pp29.44%0.00 pp18 Oct 2024NSE
Jun 202470.56%-0.06 pp29.44%+0.06 pp20 Jul 2024NSE
Mar 202470.62%0.00 pp29.38%0.00 pp18 Apr 2024NSE
Dec 202370.62%-0.01 pp29.38%+0.01 pp20 Jan 2024NSE
Sep 202370.63%0.00 pp29.37%0.00 pp20 Oct 2023NSE
Jun 202370.63%-0.03 pp29.37%+0.03 pp18 Jul 2023NSE
Mar 2023 revised70.66%+1.86 pp29.34%-1.86 pp20 Apr 2023NSE
Dec 202268.80%-0.08 pp31.20%+0.08 pp20 Jan 2023NSE
Sep 202268.88%0.00 pp31.12%0.00 pp21 Oct 2022NSE
Jun 202268.88%-0.01 pp31.12%+0.01 pp20 Jul 2022NSE
Mar 202268.89%-0.02 pp31.11%+0.02 pp07 Apr 2022NSE
Dec 202168.91%-0.12 pp31.09%+0.12 pp08 Jan 2022NSE
Sep 202169.03%-30.97%-14 Oct 2021NSE
Shareholding details

Loading...

Events

Not checked yet

BSE events come from the BSE corporate actions file, which an admin uploads. There is no automatic BSE fetch. Nothing has been imported for this stock yet.

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.